Health Care

Moderna Inc (NASDAQ:MRNA) Q4 2022 Earnings Call dated Feb. 23, 2023. Corporate Participants: Lavina Talukdar -- Head of Investor Relations Stephane Bancel -- Chief…

Moderna Inc. (NASDAQ: MRNA) reported total revenue of $5.1 billion for the fourth quarter of 2022, down 29% year-over-year due…

Medtronic PLC (NYSE: MDT) Q3 2023 earnings call dated Feb. 21, 2023 Corporate Participants: Ryan Weispfenning -- Vice President and Head of…

Medtronic plc (NYSE: MDT) reported third quarter 2023 earnings results today. Revenue of $7.7 billion was flat as reported and up 4.1%…

Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Q4 2022 earnings call dated Feb. 16, 2023 Corporate Participants: Matt Roache -- Director of Investor Relations…

Sage Therapeutics Inc (NASDAQ: SAGE) Q4 2022 earnings call dated Feb. 16, 2023 Corporate Participants: Helen Rubinstein -- Director of Investor Relations…

10X Genomics Inc (NASDAQ: TXG) Q4 2022 earnings call dated Feb. 15, 2023 Corporate Participants: Cassie Corneau -- Manager, Investor Relations and…

Biogen, Inc. (NASDAQ: BIIB) Q4 2022 earnings call dated Feb. 15, 2023 Corporate Participants: Michael Hencke -- Head of Investor Relations Christopher…

Biogen Inc. (NASDAQ: BIIB) reported fourth quarter 2022 earnings results today. Total revenue fell 7% year-over-year to $2.54 billion. Net…

Zoetis Inc (NYSE: ZTS) Q4 2022 earnings call dated Feb. 14, 2023 Corporate Participants: Steve Frank -- Vice President, Investor Relations Kristin…

AbbVie, Inc. (NYSE: ABBV) has delivered yet another quarter of strong top-line and earnings performance but issued cautious guidance for…

Ventas Inc (NYSE: VTR) Q4 2022 earnings call dated Feb. 10, 2023 Corporate Participants: BJ Grant -- Senior Vice President-Investor Relations Debra A.…

IQVIA Holdings Inc (NYSE: IQV) Q4 2022 earnings call dated Feb. 10, 2023 Corporate Participants: Nick Childs -- Senior Vice President - Investor…

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported total revenues of $2.3 billion for the fourth quarter of 2022. This compares to $2…

Veru Inc (NASDAQ: VERU) Q1 2023 earnings call dated Feb. 09, 2023 Corporate Participants: Sam Fisch -- Executive Director, Investor Relations, and Corporate…

AstraZeneca PLC (NYSE: AZN) Q4 2022 earnings call dated Feb. 09, 2023 Corporate Participants: Andy Barnett -- Vice President Global Head of Investor…

Canopy Growth Corporation (TSE: WEED) Q3 2023 earnings call dated Feb. 09, 2023 Corporate Participants: Tyler Burns -- Director, Investor Relations David…

AbbVie (NYSE: ABBV) Q4 2022 earnings call dated Feb. 09, 2023 Corporate Participants: Elizabeth Shea -- Vice President, Investor Relations Richard A.…

Humana AB (NYSE: HUM) Q4 2022 earnings call dated Feb. 09, 2023 Corporate Participants: Johanna Rastad -- Chief Executive Officer and President…

AbbVie (NYSE: ABBV) reported fourth quarter 2022 earnings results today. Worldwide net revenues increased 1.6% year-over-year to $15.1 billion. Net…

CVS Health Corporation (NYSE: CVS) Q4 2022 earnings call dated Feb. 08, 2023 Corporate Participants: Tom Kelly -- Senior Vice President of…